Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Lyophilized formulations of exendins and exendin agonist analogs

Lyophilized formulations of exendins and exendin agonist analogs

US Patent 7906146 · Granted Mar 15, 2011

Estimated economic value: $26,532,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods and compositions for treatment of microbiome associated disorders2025
Glucagon-receptor selective polypeptides and methods of use thereof2023
Methods comprising continuous administration of exenatide and co-administration 2023
Methods and compositions for treatment of microbiome-associated disorders2023
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2022
Glucagon-receptor selective polypeptides and methods of use thereof2022
Detection of rare sequence variants, methods and compositions therefor2021
Methods comprising continuous administration of a GLP-1 receptor agonist and co-2020
Bile acid recycling inhibitors for treatment of obesity and diabetes2020
Glucagon-receptor selective polypeptides and methods of use thereof2019
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2019
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity,2019